ACLU asks Supreme Court to reconsider gene patenting case

The American Civil Liberties Union has asked for a second time that the Supreme Court invalidate Myriad Genetics Inc.'s patents on two genes associated with hereditary breast and ovarian cancers, the latest salvo in a case with broad consequences for the future of gene-based medicine.

From staff and wire reports

September 25, 2012